Cristina Barlassina Selected Research

adducin

2/2010	alpha- and beta-Adducin polymorphisms affect podocyte proteins and proteinuria in rodents and decline of renal function in human IgA nephropathy.
5/2006	Alpha-adducin and angiotensin-converting enzyme polymorphisms in hypertension: evidence for a joint influence on albuminuria.
4/2006	The 460Trp allele of alpha-adducin increases carotid intima-media thickness in young adult males.
3/2005	Role of the adducin family genes in human essential hypertension.
7/2003	Genetics of human arterial hypertension.
4/2003	Haematological phenotypes in relation to the C1797T beta-adducin polymorphism in a Caucasian population.
3/2003	ACE and alpha-adducin polymorphism as markers of individual response to diuretic therapy.
12/2002	Association between hypertension and variation in the alpha- and beta-adducin genes in a white population.
8/2002	Carotid and femoral intima-media thickness in relation to three candidate genes in a Caucasian population.
2/2002	alpha-Adducin 460Trp allele is associated with erythrocyte Na transport rate in North Sardinian primary hypertensives.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cristina Barlassina Research Topics

Disease

17	Hypertension (High Blood Pressure) 01/2022 - 02/2002
7	Essential Hypertension 06/2015 - 12/2002
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 05/2003
2	Septic Shock (Toxic Shock Syndrome) 09/2021 - 11/2018
2	Shock 12/2019 - 01/2016
2	Leukemia 01/2019 - 07/2009
2	Hematologic Neoplasms (Hematological Malignancy) 01/2019 - 01/2016
2	Fibrosis (Cirrhosis) 01/2016 - 01/2004
2	Neoplasms (Cancer) 01/2016 - 07/2009
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022
1	Sepsis (Septicemia) 09/2021
1	Cardiomyopathies (Cardiomyopathy) 09/2021
1	Rubinstein-Taybi Syndrome (Syndrome, Rubinstein-Taybi) 09/2020
1	Intellectual Disability (Idiocy) 09/2020
1	Infections 12/2019
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 12/2019
1	Kidney Calculi (Kidney Stone) 10/2018
1	Diabetes Mellitus 01/2017
1	Inflammation (Inflammations) 01/2017
1	Heart Failure 01/2016
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2016
1	Myofibrillar Myopathy 01/2016
1	Atherosclerosis 01/2016
1	Multiple Sclerosis 10/2015
1	Thoracic Aortic Aneurysm 09/2015
1	Moyamoya Disease (Moya-Moya Disease) 09/2015
1	Edema (Dropsy) 05/2015
1	Vitamin K Deficiency 02/2015
1	IGA Glomerulonephritis (IGA Nephropathy) 02/2010
1	Proteinuria 02/2010
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2009
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 07/2009
1	Albuminuria 05/2006
1	Renal Insufficiency (Renal Failure) 05/2006
1	Hypertrophy 01/2004
1	Type 2 Diabetes Mellitus (MODY) 05/2003
1	Insulin Resistance 05/2003
1	Hemolysis 04/2003
1	Renal Hypertension 08/2002

Drug/Important Bio-Agent (IBA)

10	adducinIBA 02/2010 - 02/2002
6	SaltsIBA 01/2020 - 07/2003
5	Proteins (Proteins, Gene)FDA Link 01/2016 - 08/2002
4	SodiumIBA 01/2020 - 12/2002
3	Antihypertensive Agents (Antihypertensives)IBA 10/2018 - 06/2015
3	AldosteroneIBA 06/2015 - 12/2002
2	Biological ProductsIBA 01/2022 - 02/2012
2	DiureticsIBA 01/2017 - 03/2003
2	LipidsIBA 01/2016 - 05/2006
2	Pharmaceutical PreparationsIBA 11/2015 - 06/2015
2	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 06/2015 - 03/2003
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 11/2013 - 05/2003
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 05/2006 - 08/2002
2	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 01/2004 - 08/2002
1	Inositol PhosphatesIBA 01/2022
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2022
1	TroponinIBA 09/2021
1	ChromatinIBA 09/2020
1	Saline SolutionIBA 01/2020
1	Immunoglobulins (Immunoglobulin)IBA 12/2019
1	AlarminsIBA 12/2019
1	Interleukin Receptors (Interleukin Receptor)IBA 12/2019
1	Pattern Recognition ReceptorsIBA 12/2019
1	InflammasomesIBA 12/2019
1	HLA-DR Antigens (HLA-DR)IBA 01/2019
1	Sodium Chloride FDA LinkGeneric 10/2018
1	CalciumIBA 10/2018
1	claudin 14IBA 10/2018
1	HDL CholesterolIBA 01/2017
1	ZymosanIBA 01/2017
1	Hormones (Hormone)IBA 01/2017
1	Uric Acid (Urate)IBA 11/2016
1	Xanthine OxidaseIBA 11/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2016
1	PolyphenolsIBA 01/2016
1	Aryldialkylphosphatase (Paraoxonase)IBA 01/2016
1	HLA Antigens (Human Leukocyte Antigens)IBA 10/2015
1	Myosin-Light-Chain KinaseIBA 09/2015
1	Cytoplasmic DyneinsIBA 09/2015
1	Diltiazem (Cardizem)FDA LinkGeneric 06/2015
1	MorpholinosIBA 05/2015
1	Gentamicins (Gentamicin)FDA LinkGeneric 05/2015
1	Matrix Gla ProteinIBA 02/2015
1	Transcription Factors (Transcription Factor)IBA 11/2013
1	Nitric Oxide Synthase (NO Synthase)IBA 02/2012
1	Glucose (Dextrose)FDA LinkGeneric 05/2006
1	RNA (Ribonucleic Acid)IBA 01/2004
1	Amino Acids FDA Link 12/2002
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 12/2002
1	ReninIBA 12/2002
1	Tryptophan (L-Tryptophan)FDA Link 12/2002
1	Oral ContraceptivesIBA 12/2002

Therapy/Procedure

4	Therapeutics 09/2021 - 03/2003
2	Transplantation 01/2019 - 07/2009
1	Cell Transplantation 01/2019
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2016
1	Haploidentical Transplantation 07/2009
1	Stem Cell Transplantation 07/2009